Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 4

1(25.0%)

4Total

N/A(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT00451893Not ApplicableCompleted

The Significance of the Mesh Thickness in the Operation of Inguinal Hernia

Role: collaborator

NCT03097549Not ApplicableCompleted

Mobile App-treatment of Mixed and Urgency Urinary Incontinence in Women

Role: collaborator

NCT05183178Phase 4Unknown

Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome

Role: collaborator

NCT01032265Not ApplicableCompleted

Web-based Management of Female Stress Urinary Incontinence

Role: collaborator

NCT03353168Unknown

Childbirth Related Fear and Worry During Pregnancy

Role: collaborator

NCT00562679Completed

Coronary Artery Disease and Sleep Apnea

Role: collaborator

All 6 trials loaded